Inventor
VAN HUIS CHAD A
US12 patents
⚠️ This page may combine multiple inventors who share the name “VAN HUIS CHAD A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LYCERA CORP
5 patentsUS9370507B2Jun 21, 2016
Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
LYCERA CORP8 citations82
US9580391B2Feb 28, 2017
Saturated acyl guanidine for inhibition of F1F0-ATPase
LYCERA CORP4 citations72
US10189777B2Jan 29, 2019
Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease
LYCERA CORP2 citations71
US10532088B2Jan 14, 2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
LYCERA CORP2 citations68
US9920012B2Mar 20, 2018
Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
LYCERA CORP1 citations50
MERCK SHARP & DOHME
3 patentsUS9657033B2May 23, 2017
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
MERCK SHARP & DOHME20 citations91
US9266827B2Feb 23, 2016
Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME23 citations91
US10377768B2Aug 13, 2019
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME6 citations82
GLICK GARY D
3 patentsUS9139532B2Sep 22, 2015
Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereof
GLICK GARY D8 citations83
US9000014B2Apr 7, 2015
Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
GLICK GARY D12 citations82
US9512111B2Dec 6, 2016
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
GLICK GARY D21 citations81